Peijia Medical's Total Assets for the quarter that ended in Dec. 2025 was $377.2 Mil.
During the past 12 months, Peijia Medical's average Total Assets Growth Rate was 10.30% per year.
During the past 3 years, the average Total Assets Growth Rate was 9.80% per year.
During the past 5 years, the average Total Assets Growth Rate was 32.50% per year.
During the past 8 years, Peijia Medical's highest 3-Year average Total Assets Growth Rate was 127.30%. The lowest was 9.80%. And the median was 56.00%.
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Peijia Medical's Asset Turnover for the quarter that ended in Dec. 2025 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Peijia Medical Total Assets Related Terms
Peijia Medical Total Assets Historical Data
* Premium members only.
The historical data trend for Peijia Medical's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Peijia Medical's Total Assets for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peijia Medical (PEJMF) has a Total Assets of $377.2 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Peijia Medical and its competitors.
Is Peijia Medical's Total Assets too high?
Peijia Medical's current Total Assets is $377.2 Mil. Overall, Peijia Medical has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Peijia Medical's Total Assets compare to ABT and SYK?
Peijia Medical's Total Assets of $377.2 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Peijia Medical and its competitors. Peijia Medical's current Total Assets is $377.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peijia Medical stock overvalued right now?
Peijia Medical (PEJMF) has a current Total Assets of $377.2 Mil. The stock's GF Value™ is $2.84, compared to a current price of $1.39 — trading 51.2% below its estimated fair value. The current Total Assets is $377.2 Mil. Peijia Medical's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Peijia Medical (PEJMF), the current Total Assets is $377.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Peijia Medical (PEJMF) Overvalued in 2026?
Based on GuruFocus' analysis, Peijia Medical stock appears to be undervalued.
The current stock price of $1.39 is trading 51.2% below its estimated GF Value™ of $2.84.
Key valuation signals for PEJMF:
Total Assets: $377.2 Mil
GF Value™: $2.84 vs. price of $1.39 (51.2% below fair value)
No single metric tells the full story. See the PEJMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peijia Medical Ltdis a provider of inventive medical products and solutions. It focuses on the high-growth interventional procedural medical device market in China. Its products and product candidates target large, fast-growing and under-penetrated markets with high entry barriers, including the transcatheter valve therapeutic medical device market and the neurointerventional procedural medical device market. The Company's product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates spanning three key business segments: Transcatheter Valve Therapeutic Business, Future Technology Business and Neurointerventional Business.
76GF Score
Get the complete analysis for PEJMF
Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PEJMF has been successfully added to your 
